0001209191-15-014720.txt : 20150219
0001209191-15-014720.hdr.sgml : 20150216
20150217181437
ACCESSION NUMBER: 0001209191-15-014720
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150212
FILED AS OF DATE: 20150217
DATE AS OF CHANGE: 20150217
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCA biopharma, Inc.
CENTRAL INDEX KEY: 0000907654
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 363855489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
BUSINESS PHONE: 720-940-2200
MAIL ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
FORMER COMPANY:
FORMER CONFORMED NAME: NUVELO INC
DATE OF NAME CHANGE: 20030203
FORMER COMPANY:
FORMER CONFORMED NAME: HYSEQ INC
DATE OF NAME CHANGE: 19970610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ozeroff Christopher David
CENTRAL INDEX KEY: 0001454996
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22873
FILM NUMBER: 15624893
MAIL ADDRESS:
STREET 1: 8001 ARISTA PLACE
STREET 2: SUITE 200
CITY: BROOMFIELD
STATE: CO
ZIP: 80021
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-02-12
0
0000907654
ARCA biopharma, Inc.
ABIO
0001454996
Ozeroff Christopher David
ARCA BIOPHARMA, INC.
11080 CIRCLEPOINT ROAD, SUITE 140
WESTMINSTER
CO
80020
0
1
0
0
S.V.P., General Counsel
Common Stock
2015-02-12
4
A
0
24050
0.00
A
150787
D
Stock Option (right to buy)
0.67
2015-02-12
4
A
0
12950
0.00
A
2025-02-11
Common Stock
12950
12950
D
Represents shares issued as restricted stock units (an "RSU") under the Issuer's 2013 Equity Incentive Plan (the "Plan"). The RSUs vest in three equal annual installments beginning April 2, 2016, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time.
Includes 84,200 previously reported shares issued as restricted stock units under the Plan and 42,537 previously reported shares of common stock held directly.
Grant to the Reporting Person of a stock option under the Plan, vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested.
/s/ Brian L. Selby, Attorney-in-Fact
2015-02-17